Physician Wealth Advisors’s T. Rowe Price Capital Appreciation Equity ETF TCAF Stock Holding History
Bought
Maintained
Sold
Other funds holding TCAF
Physician Wealth Advisors's TCAF Position: Q2 2026 in Review
Physician Wealth Advisors reduced its T. Rowe Price Capital Appreciation Equity ETF (TCAF) stake by 4.5% in Q2 2026, selling an estimated $1.07K and leaving 573 shares worth $23.6K. The position accounts for ﹤0.01% of the portfolio, ranked #613.
Physician Wealth Advisors first reported a position in TCAF in Q1 2026 and has held it in 2 quarters since. 357 funds tracked by Wall St. Rank hold TCAF as of Q2 2026.
- Physician Wealth Advisors held 573 shares of T. Rowe Price Capital Appreciation Equity ETF worth $23.6K as of Q2 2026.
- Physician Wealth Advisors sold 27 T. Rowe Price Capital Appreciation Equity ETF shares in Q2 2026, an estimated $1.07K.
- T. Rowe Price Capital Appreciation Equity ETF made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #613 holding.
- Physician Wealth Advisors first reported a position in T. Rowe Price Capital Appreciation Equity ETF in Q1 2026 and has held it in 2 quarters since.
- 357 funds tracked by Wall St. Rank held T. Rowe Price Capital Appreciation Equity ETF as of Q2 2026.
Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.